Nephrogenic systemic fibrosis

Results: 47



#Item
1Contrast enhancement in MR imaging: New options, new techniques, new opportunities  Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRM

Contrast enhancement in MR imaging: New options, new techniques, new opportunities Nephrogenic systemic fibrosis update 2014: Fact versus theory Emanuel Kanal, MD, FACR, FISMRM

Add to Reading List

Source URL: cdn.agilitycms.com

Language: English - Date: 2015-05-13 14:14:19
    2[removed]  ® HIGHLIGHTS OF PRESCRIBING INFORMATION

    [removed] ® HIGHLIGHTS OF PRESCRIBING INFORMATION

    Add to Reading List

    Source URL: www.lantheus.com

    Language: English - Date: 2014-01-01 15:09:52
    3HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2014-11-17 14:53:23
    4OPTIMARK (gadoversetamide) injection Label

    OPTIMARK (gadoversetamide) injection Label

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2014-11-25 11:08:36
    5FDA Patient Safety News: Show #54, August 2006

    FDA Patient Safety News: Show #54, August 2006

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    6Omniscan (gadodiamide) injection label

    Omniscan (gadodiamide) injection label

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2010-12-21 14:44:58
    7Prohance (gadoteridol) injection label

    Prohance (gadoteridol) injection label

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2010-12-21 14:29:00
    8Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist

    Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist

    Add to Reading List

    Source URL: www.hma.eu

    Language: English - Date: 2014-04-01 10:51:04
    9Microsoft Word - 2-New Omniscan_ACM_Brief_ver5.doc

    Microsoft Word - 2-New Omniscan_ACM_Brief_ver5.doc

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    10U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

    U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

    Add to Reading List

    Source URL: www.fda.gov

    Language: English